subscribeSubscribe
price-trendAsk Us
AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma

AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma
PHARMABIZ
06 Jan 2022
Share Share
AstraZeneca sells 2 COPD inhalers to familiar face

AstraZeneca sells 2 COPD inhalers to familiar face
Angus Liu FIERCEPHARMA
02 Nov 2021
Share Share
A three-decade monopoly: How Amgen built a patent thicket top-selling drug

A three-decade monopoly: How Amgen built a patent thicket top-selling drug
Jonathan Gardner BIOPHARMADIVE
30 Oct 2021
Share Share
Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD

Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD
BIOSPACE
21 Oct 2019
Share Share
US Food and Drug Administration Approves DUAKLIR® PRESSAIR®

US Food and Drug Administration Approves DUAKLIR® PRESSAIR®
BUSINESSWIRE
17 Apr 2019
Share Share
FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) sNDA)

FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) sNDA)
BUSINESSWIRE
01 Apr 2019
Share Share
AZ’ Tudorza hits study goals in COPD patients with CV risk factors

AZ’ Tudorza hits study goals in COPD patients with CV risk factors
Selina McKee PHARMA TIMES
05 Dec 2017
Share Share
AZ announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD

AZ announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD
PHARMABIZ
04 Dec 2017
Share Share
Five pharmas Fall Foul of ABPI Code of Practice

Five pharmas Fall Foul of ABPI Code of Practice
Selina McKee PHARMATIMES
15 Dec 2016
Share Share
US FDA Enforcement report- 30/Mar/2016

US FDA Enforcement report- 30/Mar/2016
FDA
28 Mar 2016
Share Share